Company Staidson (Beijing) BioPharmaceuticals Co., Ltd.

300204

CNE100001237

Pharmaceuticals

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Holdings

Company contact information

Sector

Sector Biopharmaceuticals

STAIDSON (BEIJING) BIOPHARMACEUTICALS CO., LTD.

End-of-day quote Shenzhen S.E. Other stock markets 06:00:00 2024-04-24 pm EDT			5-day change	1st Jan Change
6.44 ^CNY	+8.60%		+8.42%	-36.61%

Apr. 24	Staidson BioPharmaceuticals Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Mar. 25	Staidson BioPharmaceuticals Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Staidson (Beijing) Biopharmaceuticals Co., Ltd. is a China-based company principally engaged in the research, development, manufacture and sales of innovative therapeutic medicine with independent intellectual property rights including protein medicine, genetic medicine and chemical medicine, among others. The Companyâs products include mouse nerve growth factor for injection, which are applied in the neuroprotection and treatment of nerve injuries, as well as polyethylene glycol electrolyte powders, which are applied in the bowel cleansing and treatment of constipation. The Company mainly distributes its products in domestic market.

Number of employees: 555

CNY in Million	2022	Weight	2023	Weight	Delta
Pharmaceutical Manufacturing 100.0 %	549	100.0 %	364	100.0 %	-33.66%

CNY in Million	2022	Weight	2023	Weight	Delta
China 100.0 %	549	100.0 %	364	100.0 %	-33.66%

Managers	Title	Age	Since
Chao Wang CEO	Chief Executive Officer	42	11-06-30
Shi Cheng Li DFI	Director of Finance/CFO	42	20-08-25
Zhi Wen Zhou PSD	President	59	01-12-31
Hong Shan Zhang CHM	Chairman	60	01-12-31
Rong Qin Zhang BRD	Director/Board Member	56	03-12-31
Ji Guang Zhao PRN	Corporate Officer/Principal	49	20-03-31

Members of the board	Title	Age	Since
Hong Shan Zhang CHM	Chairman	60	01-12-31
Zhi Wen Zhou CHM	Chairman	59	01-12-31
Tao Li BRD	Director/Board Member	61	07-12-31
Rong Qin Zhang BRD	Director/Board Member	56	03-12-31
Ying Sun BRD	Director/Board Member	62	18-09-16
Hong Zheng BRD	Director/Board Member	53	21-08-10
Li Zhao BRD	Director/Board Member	67	21-08-10
Lian Chun Yang BRD	Director/Board Member	59	21-08-10
Jia Jun Zhao BRD	Director/Board Member	63	21-08-10
Hong Liu		-	-

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	477,772,555	121,574,929 ( 25.45 %)	0	25.45 %

Name	Equities	%	Valuation
Jian Ping Gu 8.845 %	41,517,775	8.845 %	39 M ¥
Zhen Qi Gu 0.6446 %	3,025,840	0.6446 %	3 M ¥
China Asset Management Co., Ltd. 0.0993 %	466,300	0.0993 %	436 140 ¥
China Southern Asset Management Co., Ltd. 0.0880 %	413,100	0.0880 %	386 381 ¥
Fullgoal Fund Management Co., Ltd. 0.0465 %	218,300	0.0465 %	204 180 ¥
GF Fund Management Co., Ltd. 0.0387 %	181,500	0.0387 %	169 761 ¥
Hong Zheng 0.006125 %	28,750	0.006125 %	26 890 ¥
China Life AMP Asset Management Co., Ltd. 0.004261 %	20,000	0.004261 %	18 706 ¥
Truvalue Asset Management Co. Ltd. 0.001704 %	8,000	0.001704 %	7 483 ¥
Huatai-PineBridge Fund Management Co., Ltd. 0.001065 %	5,000	0.001065 %	4 677 ¥

Name	Equities	%	Valuation
Hong Zheng 1.443 %	86,250	1.443 %	80 671 ¥

Name	Equities	%	Valuation
INFLARX N.V. 9.74%	5,733,910	9.74%	8,830,221 $

Staidson (Beijing) Biopharmaceuticals Co., Ltd.

36 Jinghai 2nd Road Beijing Economic Tech Dev Area

100176, Beijing

http://www.staidson.com

address Staidson (Beijing) BioPharmaceuticals Co., Ltd.(300204)

Healthcare

Pharmaceuticals & Medical Research

Pharmaceuticals

Pharmaceuticals

Biopharmaceuticals

	1st Jan change	Capi.
STAIDSON (BEIJING) BIOPHARMACEUTICALS CO., LTD.	-36.61%	391M
CSL LIMITED	-2.86%	87.31B
SAMSUNG BIOLOGICS CO.,LTD.	+2.63%	40.86B
BIOGEN INC.	-21.76%	29.36B
UCB	+58.56%	24.49B
BIOMARIN PHARMACEUTICAL INC.	-14.78%	17.31B
INCYTE CORPORATION	-18.49%	11.62B
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD.	-15.61%	11.31B
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD.	-44.02%	11.26B
SWEDISH ORPHAN BIOVITRUM AB	+5.17%	8.31B

Biopharmaceuticals